Craig Young, Ph.D. Email & Phone Number

Singapore

London, United Kingdom

Advisory and broking coverage for retained FTSE 100 and FTSE 250 clients, along with new client origination and transaction execution. Proactively created new opportunities and effected introductions to develop other areas of business. Contributed to the overall development of the team, including recruitment, staff welfare and managing performance issues. Team staffer since joining UBS, managing workloads for Associates and below.Key highlights:▪ Integral to clients’ strategic… Show more Advisory and broking coverage for retained FTSE 100 and FTSE 250 clients, along with new client origination and transaction execution. Proactively created new opportunities and effected introductions to develop other areas of business. Contributed to the overall development of the team, including recruitment, staff welfare and managing performance issues. Team staffer since joining UBS, managing workloads for Associates and below.Key highlights:▪ Integral to clients’ strategic advisory and IR teams, providing ongoing counsel and strategic input.▪ Consistently delivered high quality client service and ensured retention. Highly commended by clients and stakeholders from markets, research and the buy-side.▪ SPAC IPO of Admiral Acquisition Limited ($550m, May 2023).▪ Corporate broking mandate win for Haleon (Jul 2022). Show less

London, United Kingdom

London, United Kingdom

Part of the EMEA M&A team, executing and originating buy-side and sell-side deal mandates for corporate and sponsor clients. Frequent cross-border and cross-sector collaboration. Highly ranked within peer group.Key highlights:▪ Sale of a 53% stake in the Coca-Cola Bottling Company of Egypt to CCH ($427m total, completed Jan 2022).▪ Sale of Takeda’s TachoSil Fibrin Sealant Patch to Corza Health (€350m, completed Feb 2021).▪ Acquisition of Medipass (European business) by DWS… Show more Part of the EMEA M&A team, executing and originating buy-side and sell-side deal mandates for corporate and sponsor clients. Frequent cross-border and cross-sector collaboration. Highly ranked within peer group.Key highlights:▪ Sale of a 53% stake in the Coca-Cola Bottling Company of Egypt to CCH ($427m total, completed Jan 2022).▪ Sale of Takeda’s TachoSil Fibrin Sealant Patch to Corza Health (€350m, completed Feb 2021).▪ Acquisition of Medipass (European business) by DWS (€169m, completed Nov 2020).▪ Acquisition of a 30% stake in Haldor Topsøe by Temasek (n.d., completed Jul 2019).▪ Acquisition of Fuller’s Beer Business by Asahi Europe (£250m, completed Apr 2019).▪ Acquisition of Shire by Takeda Pharmaceutical Company ($79bn, completed Jan 2019). Show less

London, United Kingdom

London, United Kingdom

London, United Kingdom

Supported senior bankers on origination and transaction execution, focusing on advisory to FTSE 100 and 250 clients.Key highlights:▪ Acquisition of Invensys by Schneider Electric (£3.4bn, completed Jan 2014).▪ Demerger of Cookson into Alent and Vesuvius (£1.8bn, completed Dec 2012).▪ Equity placings for Rockhopper (£47m, Oct 2011) and Redrow (£80m, Apr 2012).

Ph.D., Chemistry

Focus on Catalysis, Sustainability and Applied Inorganics. Thesis title: "Ethylene Oligomerisation and Polymerisation: Catalyst Synthesis.

Msci, Chemistry, 1St Class.

Activities and Societies: President, Imperial College Finance Society. ▪ 1st Class Honours. Ranked in the top 10% of final year MSci.